0001104659-20-011515.txt : 20200205
0001104659-20-011515.hdr.sgml : 20200205
20200205205741
ACCESSION NUMBER: 0001104659-20-011515
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200205
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BILL & MELINDA GATES FOUNDATION TRUST
CENTRAL INDEX KEY: 0001166559
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 20580622
BUSINESS ADDRESS:
STREET 1: 2365 CARILLON POINT
CITY: KIRKLAND
STATE: WA
ZIP: 98033
BUSINESS PHONE: 4258897900
MAIL ADDRESS:
STREET 1: 2365 CARILLON POINT
CITY: KIRKLAND
STATE: WA
ZIP: 98033
FORMER NAME:
FORMER CONFORMED NAME: GATES BILL & MELINDA FOUNDATION
DATE OF NAME CHANGE: 20020205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
3
1
a3.xml
3
X0206
3
2020-02-05
0
0001490978
Schrodinger, Inc.
SDGR
0001166559
BILL & MELINDA GATES FOUNDATION TRUST
2365 CARILLON POINT
KIRKLAND
WA
98033
0
0
1
0
Series B preferred stock
Common Stock
3942041
D
Series C preferred stock
Common Stock
6319743
D
Series D preferred stock
Common Stock
4808612
D
Series E preferred stock
Common Stock
4487226
D
All shares of Series B preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's initial public offering ("IPO"), unless voluntarily exchanged at the discretion of Bill & Melinda Gates Foundation Trust (the "Trust") into the Issuer's limited common stock on a 7.47534-for-1 basis. The Trust expects to exchange all of its Series B preferred stock into the Issuer's limited common stock upon the closing of the Issuer's IPO.
All shares of Series C preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's IPO, unless voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis. The Trust expects to exchange all of its Series C preferred stock into the Issuer's limited common stock upon the closing of the Issuer's IPO.
All shares of Series D preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's IPO, unless voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis. The Trust expects its Series D preferred stock to be exchanged into 2,902,409 shares of the Issuer's limited common stock and 1,906,203 shares of the Issuer's common stock upon the closing of the Issuer's IPO.
All shares of Series E preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's IPO.
Duly authorized under Special Limited Power of Attorney appointing Alan Heuberger attorney-in-fact, dated August 12, 2008, by and on behalf of William H. Gates III and Melinda French Gates as Co-Trustees, filed as Exhibit 99.5 to Cascade Investment L.L.C.'s Schedule 13D with respect to Grupo Televisa, S.A.B. on May 7, 2009, SEC File No. 005-60431, and incorporated by reference herein.
Bill & Melinda Gates Foundation Trust By: /s/ Alan Heuberger, Attorney-in-fact for each of the Co-Trustees, William H. Gates III and Melinda French Gates (See Remarks)
2020-02-05